Galmed Pharmaceuticals
GLMD
GLMD
24 hedge funds and large institutions have $7.05M invested in Galmed Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
40% less capital invested
Capital invested by funds: $11.8M → $7.05M (-$4.75M)
88% less call options, than puts
Call options by funds: $51K | Put options by funds: $429K
Holders
24
Holding in Top 10
–
Calls
$51K
Puts
$429K
Top Buyers
| 1 | +$163K | |
| 2 | +$73.4K | |
| 3 | +$65K | |
| 4 |
LC
Lindbrook Capital
Calabasas,
California
|
+$21K |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$13K |
Top Sellers
| 1 | -$581K | |
| 2 | -$140K | |
| 3 | -$98K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$78K |
| 5 |
Squarepoint
New York
|
-$71K |